Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22653 | 0.83 | — | — | |
| SCHEMBL28830260 | 0.81 | SMPD1 (0.32) | TSHR | |
| SCHEMBL6998228 | 0.81 | SMPD1 (0.32) | TSHR | |
| Pyridine SCHEMBL27519759 | 0.77 | TDP1 (0.35) | TSHRNAPRTTDP1 | |
| SCHEMBL8443992 | 0.74 | — | — | |
| SCHEMBL7913004 | 0.73 | ALDH1A1 (0.35) | TSHR | |
| Pyridine SCHEMBL11782297 | 0.72 | TSHR (0.38) | TSHRNAPRTTDP1 | |
| Pyridine SCHEMBL29270057 | 0.71 | TSHR (0.33) | TSHRNAPRTTDP1 | |
| Phosphoric Acid Monomethyl Ester SCHEMBL21054851 | 0.71 | TDP1 (0.45) | TSHRNAPRTTDP1 | |
| Phosphoric Acid Monomethyl Ester SCHEMBL21054852 | 0.71 | TDP1 (0.45) | TSHRNAPRTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1085909-B1 | A complex of alpha-fetoprotein (AFP) and a polyunsaturated fatty acid derivative for the treatment of immune deficiencies | ARDENIA INVESTMENTS LTD (GI) | 2005-12-28 | — | — | EP | disclosed |
| US-6599507-B2 | Immunostimulation | ARDENIA INVESTMENTS, LTD. (GI) | 2003-07-29 | — | — | US | disclosed |
| EP-1161436-B1 | Polyunsaturated fatty acid derivatives and their use in the treatment of cancer | ARDENIA INVESTMENTS LTD (GI) | 2003-06-25 | — | — | EP | disclosed |
| US-6403554-B2 | Polyunsaturated fatty acid derivatives and their use | ARDENIA INVESTMENTS LTD. (GI) | 2002-06-11 | — | — | US | disclosed |
| EP-1161436-A1 | POLYUNSATURATED FATTY ACID DERIVATIVES AND THEIR USE | Ardenia Investments Ltd. (GI) | 2001-12-12 | — | — | EP | disclosed |
| US-20010037032-A1 | Polyunsaturated fatty acid derivatives and their use | OASMIA PHARMACEUTICAL AB (SE) | 2001-11-01 | — | — | US | disclosed |
| US-20010034324-A1 | Composition for the treatment of immune deficiencies and methods for its preparation and use | OASMIA PHARMACEUTICAL AB (SE) | 2001-10-25 | — | — | US | disclosed |
| US-6274747-B1 | COMPOUNDS CONTAINING A PHOSPHATE GROUP AND SECONDARY AMIDE GROUP; ANTICANCER AGENTS | ARDENIA INVESTMENTS LTD. (GI) | 2001-08-14 | — | — | US | disclosed |
| EP-1085909-A2 | COMPOSITION FOR THE TREATEMENT OF IMMUNE DEFICIENCIES AND METHODS FOR ITS PREPARATION AND USE | Ardenia Investments Ltd. (GI) | 2001-03-28 | — | — | EP | disclosed |
| WO-2000047589-A1 | POLYUNSATURATED FATTY ACID DERIVATIVES AND THEIR USE | ARDENIA INVESTMENTS LTD. (SE) | 2000-08-17 | — | — | WO | disclosed |
| WO-1999065936-A2 | COMPOSITION FOR THE TREATEMENT OF IMMUNE DEFICIENCIES AND METHODS FOR ITS PREPARATION AND USE | ARDENIA INVESTMENTS LTD. (GI) | 1999-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010034324-A1 | Composition for the treatment of immune deficiencies and methods for its preparation and use | ALB, NAPEPLD, TTPA | TSHR 3707/4885NAPRT 378/4885TDP1 2867/4885 |
| US-20010037032-A1 | Polyunsaturated fatty acid derivatives and their use | RXRA, RXRB, LPAR2 | TSHR 259/4885NAPRT 1038/4885TDP1 1383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.